相关实验视频

Updated: Jun 24, 2025

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels

Published on: August 7, 2017

在丹麦,为患有无topic疾病的儿童提供推途径

Gitte Færk¹, Malin Glindvad Ahlström², Viktoria Helt-Eggers Lura³

¹Department of Dermatology and Allergy, Copenhagen University Hospital - Herlev and Gentofte, Denmark, The Research Unit for General Practice and Section of General Practice, Department of Public Health, University of Copenhagen, Denmark, and National Allergy Research Center, Copenhagen University Hospital - Herlev and Gentofte, Denmark. gitte.faerk@sund.ku.dk.

Acta dermato-venereologica

|June 3, 2024

概括

患有多种无性疾病的儿童,如食物过敏和喘,在复杂的丹麦医疗保健途径中进行导航. 他们比专家更常被转诊到医院,尤其是严重病情.

科学领域:

儿科过敏和免疫学
医疗保健导航导航
丹麦公共卫生丹麦公共卫生

背景情况:

亚托皮性疾病 (皮炎,食物过敏,犀牛结膜炎,喘) 在全球普遍存在.
丹麦的医疗保健系统具有复杂的特点,对这些疾病的转诊途径不太了解.
了解患者导航对于优化护理提供至关重要.

研究的目的:

为了阐明丹麦的亚托皮性疾病儿童的医疗护理导航模式.
识别影响推途径到专家和医院部门的因素.
分析疾病多样性和特定条件对获得医疗保健的影响.

主要方法:

一项基于问卷的研究,涉及279名儿童 (≤17岁) 在2020年8月至2021年6月期间接受了亚托皮性疾病治疗.
从丹麦首都地区的患者收集的数据,从从业专家或医院部门接受护理.
统计分析,包括赔率比率 (OR) 和95%置信区间 (CI),以确定转诊决定因素.

主要成果:

大多数儿童最初由他们的全科医生转介给专家或医院.
对于患有三种或三种以上的亚托皮性疾病的患者,没有确定标准化的转诊途径.
患有多重亚托皮性疾病 (≥3) 的患者显示,转诊到医院的可能性显著更高 (OR 3.79).
食物过敏 (OR 4.69) 和喘 (OR 2.58) 是医院治疗的主要驱动因素.

结论:

在丹麦,患有多种亚托皮性疾病的儿童面临着分散的医疗护理导航.
与实践专家相比,这些儿童更常被转诊到医院部门.
食物过敏似乎是需要医院级护理的关键因素,突出需要简化管理策略.

更多相关视频

Effects of Exposure of Formaldehyde to a Rat Model of Atopic Dermatitis Induced by Neonatal Capsaicin Treatment

Effects of Exposure of Formaldehyde to a Rat Model of Atopic Dermatitis Induced by Neonatal Capsaicin Treatment

Published on: September 27, 2017

Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach

Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach

Published on: September 26, 2019

相关概念视频

Asthma-II: Pathophysiology and Classification

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:

Asthma: Pathogenesis and Management

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.

Allergic Reactions

Allergic Reactions

Asthma-I: Introduction

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...